652 related articles for article (PubMed ID: 9312023)
1. Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their Kit ligand-dependent proliferation.
Quang CT; Wessely O; Pironin M; Beug H; Ghysdael J
EMBO J; 1997 Sep; 16(18):5639-53. PubMed ID: 9312023
[TBL] [Abstract][Full Text] [Related]
2. SPI-1 transforming properties depend upon specifically activated forms of the EPOR.
Pereira R; Raingeaud J; Pironin M; Ghysdael J; Quang CT
Oncogene; 2000 Oct; 19(44):5106-10. PubMed ID: 11042699
[TBL] [Abstract][Full Text] [Related]
3. FLI-1 inhibits differentiation and induces proliferation of primary erythroblasts.
Pereira R; Quang CT; Lesault I; Dolznig H; Beug H; Ghysdael J
Oncogene; 1999 Feb; 18(8):1597-608. PubMed ID: 10102630
[TBL] [Abstract][Full Text] [Related]
4. Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage.
Kelley LL; Hicks GG; Hsieh FF; Prasher JM; Green WF; Miller MD; Eide EJ; Ruley HE
Oncogene; 1998 Sep; 17(9):1119-30. PubMed ID: 9764822
[TBL] [Abstract][Full Text] [Related]
5. Spi-1 and mutant p53 regulate different aspects of the proliferation and differentiation control of primary erythroid progenitors.
Quang CT; Pironin M; von Lindern M; Beug H; Ghysdael J
Oncogene; 1995 Oct; 11(7):1229-39. PubMed ID: 7478542
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Friend cells proliferation by spi-1 antisense oligodeoxynucleotides.
Delgado MD; Hallier M; Meneceur P; Tavitian A; Moreau-Gachelin F
Oncogene; 1994 Jun; 9(6):1723-7. PubMed ID: 8183568
[TBL] [Abstract][Full Text] [Related]
7. Subtle distinct regulations of late erythroid molecular events by PI3K/AKT-mediated activation of Spi-1/PU.1 oncogene autoregulation loop.
Breig O; Théoleyre O; Douablin A; Baklouti F
Oncogene; 2010 May; 29(19):2807-16. PubMed ID: 20190819
[TBL] [Abstract][Full Text] [Related]
8. C-myc expression affects proliferation but not terminal differentiation or survival of explanted erythroid progenitor cells.
Bondurant MC; Yamashita T; Muta K; Krantz SB; Koury MJ
J Cell Physiol; 1996 Aug; 168(2):255-63. PubMed ID: 8707861
[TBL] [Abstract][Full Text] [Related]
9. Spi-1 transgenic mice develop a clonal erythroleukemia which does not depend on p53 mutation.
Barnache S; Wendling F; Lacombe C; Denis N; Titeux M; Vainchenker W; Moreau-Gachelin F
Oncogene; 1998 Jun; 16(23):2989-95. PubMed ID: 9662331
[TBL] [Abstract][Full Text] [Related]
10. Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor.
Li JP; D'Andrea AD; Lodish HF; Baltimore D
Nature; 1990 Feb; 343(6260):762-4. PubMed ID: 2154701
[TBL] [Abstract][Full Text] [Related]
11. Physician Education: The Erythropoietin Receptor and Signal Transduction.
Yoshimura A; Arai K
Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
[TBL] [Abstract][Full Text] [Related]
12. Oncogene cooperativity in Friend erythroleukemia: erythropoietin receptor activation by the env gene of SFFV leads to transcriptional upregulation of PU.1, independent of SFFV proviral insertion.
Afrikanova I; Yeh E; Bartos D; Watowich SS; Longmore GD
Oncogene; 2002 Feb; 21(8):1272-84. PubMed ID: 11850847
[TBL] [Abstract][Full Text] [Related]
13. The role of Ets family transcription factor PU.1 in hematopoietic cell differentiation, proliferation and apoptosis.
Oikawa T; Yamada T; Kihara-Negishi F; Yamamoto H; Kondoh N; Hitomi Y; Hashimoto Y
Cell Death Differ; 1999 Jul; 6(7):599-608. PubMed ID: 10453070
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin mediates terminal granulocytic differentiation of committed myeloid cells with ectopic erythropoietin receptor expression.
Arcasoy MO; Maun NA; Perez L; Forget BG; Berliner N
Eur J Haematol; 2001 Aug; 67(2):77-87. PubMed ID: 11722594
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STAT5 activation.
Chrétien S; Varlet P; Verdier F; Gobert S; Cartron JP; Gisselbrecht S; Mayeux P; Lacombe C
EMBO J; 1996 Aug; 15(16):4174-81. PubMed ID: 8861946
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of the Spi-1/PU.1 oncogene induces the expression of TRIM10/HERF1, a key factor required for terminal erythroid cell differentiation and survival.
Blaybel R; Théoleyre O; Douablin A; Baklouti F
Cell Res; 2008 Aug; 18(8):834-45. PubMed ID: 18560381
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin receptor binds to Friend virus gp55 through other membrane components.
Kishi A; Chiba T; Sugiyama M; Machide M; Nagata Y; Amanuma H; Taira H; Katsumata T; Todokoro K
Biochem Biophys Res Commun; 1993 May; 192(3):1131-8. PubMed ID: 8507186
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin-dependent autocrine secretion of tumor necrosis factor-alpha in hematopoietic cells modulates proliferation via MAP kinase--ERK-1/2 and does not require tyrosine docking sites in the EPO receptor.
Chen J; Jacobs-Helber SM; Barber DL; Sawyer ST
Exp Cell Res; 2004 Aug; 298(1):155-66. PubMed ID: 15242770
[TBL] [Abstract][Full Text] [Related]
19. Leukemic transformation of normal murine erythroid progenitors: v- and c-ErbB act through signaling pathways activated by the EpoR and c-Kit in stress erythropoiesis.
von Lindern M; Deiner EM; Dolznig H; Parren-Van Amelsvoort M; Hayman MJ; Mullner EW; Beug H
Oncogene; 2001 Jun; 20(28):3651-64. PubMed ID: 11439328
[TBL] [Abstract][Full Text] [Related]
20. Activation of 70-kDa S6 kinase, induced by the cytokines interleukin-3 and erythropoietin and inhibited by rapamycin, is not an absolute requirement for cell proliferation.
Calvo V; Wood M; Gjertson C; Vik T; Bierer BE
Eur J Immunol; 1994 Nov; 24(11):2664-71. PubMed ID: 7957559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
